Cyclopropylamine → HCID 42630016, compound
Reaction equation
C(O[C:4]([C:6]1[N:7]=[N:8][C:9]([O:12][CH2:13][C:14]2[C:15]([C:20]3[CH:25]=[CH:24][C:23]([F:26])=[CH:22][CH:21]=3)=[N:16][O:17][C:18]=2[CH3:19])=[CH:10][CH:11]=1)=[O:5])C.[CH:27]1([NH2:30])[CH2:29][CH2:28]1>>[CH:27]1([NH:30][C:4]([C:6]2[N:7]=[N:8][C:9]([O:12][CH2:13][C:14]3[C:15]([C:20]4[CH:21]=[CH:22][C:23]([F:26])=[CH:24][CH:25]=4)=[N:16][O:17][C:18]=3[CH3:19])=[CH:10][CH:11]=2)=[O:5])[CH2:29][CH2:28]1Participants
3
Procedure
As described for example 59, 6-[3-(4-fluoro-phenyl)-5-methyl-isoxazol-4-ylmethoxy]-pyridazine-3-carboxylic acid ethyl ester (143 mg, 0.4 mmol) was converted, using cyclopropylamine instead of aminomethylcyclopropane, to the title compound (118 mg, 80%) which was obtained as a white solid. MS: m/e=369.1 [M+H]+.
Sources & evidence
- ORD record
- ord-f14a4bf0507545388b8869c4d4d673c0
- Source dataset
- uspto-grants-2011_05
- Patent number
- US07943619B2
Reaction notes
Loading…